Coty Inc. faces a class action lawsuit filed by Bronstein, Gewirtz & Grossman, LLC, alleging the company made materially false and misleading statements over a three-month period.
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
The complaint alleges that between November 5, 2025, and February 4, 2026, Coty failed to disclose slowing growth in its Consumer Beauty segment, decelerating growth in its Prestige fragrance business, and that margins were being pressured by increased marketing expenditures. These issues, the complaint claims, made the company's positive statements about its fiscal 2026 prospects materially misleading.
Investors who purchased Coty securities during the class period have until May 22, 2026, to request appointment as lead plaintiff. The lawsuit seeks to recover damages for investors who allegedly suffered losses due to the company's purported misrepresentations.
The lawsuit announced by Bronstein, Gewirtz & Grossman is one of multiple legal actions facing the beauty company. The Law Offices of Frank R. Cruz also announced a similar lawsuit, encouraging investors who suffered losses to participate.
Both complaints center on the same core allegations: that Coty presented an overly optimistic picture of its business operations and financial prospects for fiscal year 2026 while allegedly concealing underperformance in key segments. The lawsuits claim that the company's growth in the competitive beauty market was weakening, contrary to its public statements.
Specifically, the filings point to underperformance in the Consumer Beauty division and a slowdown in the high-margin Prestige fragrance category. The lawsuits also allege that increased marketing costs were compressing the company's margins, a fact that was not adequately disclosed to investors.
The filing of the class action lawsuit could expose Coty to significant financial liabilities and damage its reputation among investors. Shareholders will be watching for the company's official response to the allegations and any potential impact on its stock price as the May 22 lead plaintiff deadline approaches.
This article is for informational purposes only and does not constitute investment advice.